Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-Vs-Host Disease.

Ferrándiz-Pulido, C

Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-Vs-Host Disease. / Imatinib: una nueva herramienta para el manejo de la enfermedad del injerto contra el hospedador crónica esclerodermiforme.

Ferrándiz-Pulido, C.

Affiliation

Ferrándiz-Pulido C; Servicio de Dermatología, Hospital Universitario Vall d'Hebron, Barcelona Sección: Comentario Editorial. Electronic address: 40879cfp@comb.cat.

Actas Dermosifiliogr (Engl Ed) ; 109(3): 200-201, 2018 Apr.

Article in En, Es | MEDLINE | ID: mdl-29429550

Subject(s)

Graft vs Host Disease/drug therapy; Imatinib Mesylate/therapeutic use; Scleroderma, Localized/drug therapy; Chronic Disease; Graft vs Host Disease/complications; Humans; Scleroderma, Localized/complications

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Localized / Imatinib Mesylate / Graft vs Host Disease Limits: Humans Language: En / Es Journal: Actas Dermosifiliogr (Engl Ed) Year: 2018 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google